Nippon Venture Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
Professionals
  • Investments
  • 82
  • Portfolio
  • 40
  • Exits
  • 25
Exits

Nippon Venture Capital General Information

Description

Nippon Venture Capital is the corporate venture arm of Nippon Telegraph and Telephone Corporation. The firm is focused on investing in seed, start-up and early stage companies operating in the communications, software, systems and devices, life sciences and environmental technologies sectors.

Contact Information

Website
Year Founded
1966
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 2-4-1 Marunouchi
  • Chiyoda-ku
  • Tokyo, 100-6334
  • Japan
+81 00-0000-0000

Nippon Venture Capital Investments (82)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
J Pharma 06-Jan-2021 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2
0000 & 0000000 16-Sep-2020 00000 00000 0000 Consumer Finance Generating Revenue
0000 0000000 01-Sep-2020 00000 00000 00.00 Drug Discovery Generating Revenue 000000 000000
000000 20-Jul-2020 00000 00000 00.000 Entertainment Software Generating Revenue
000000 13-Mar-2020 00000 00000 00.000 Business/Productivity Software Generating Revenue 000000 000000
00000 000000 26-Dec-2019 0000 00000 00.000 Business/Productivity Software Generating Revenue 000000 000000
000000000 (0000000 22-Nov-2019 00000 00000 000.00 Decision/Risk Analysis Generating Revenue
000000 0000 21-Nov-2019 00000 00000 00.00 Network Management Software Generating Revenue
Next Innovation 01-Aug-2019 Early Stage VC Practice Management (Healthcare) Generating Revenue
Chordia Therapeutics 29-Mar-2019 Early Stage VC 0000 Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 82 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nippon Venture Capital Exits (25)

Company Name Exit Date Exit Type Exit Size
Kringle Pharma 28-Dec-2020 IPO 00.000
00000 17-Dec-2020 000 00.000
00000 24-Jun-2020 000
0000000 000000 01-Nov-2019 000 00 00000000
00000 20-Aug-2019 000000000000000000
00000000 0000 01-Feb-2019 000 00 00000000
000000 000000000 15-Jan-2019 000000000000000000
0000000000 22-Aug-2018 000 00.000
Bplats 04-Apr-2018 IPO 00.000
Smart Insight 16-Oct-2017 Out of Business
You’re viewing 10 of 25 exits. Get the full list »

Nippon Venture Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nippon Venture Capital Team (12)

Name Title Deals Funds Boards Office
Minoru Tagaya President & Board Member 0 0 0 Tokyo, Japan
Koichiro Kiyonaga Director, Managing Executive Officer and Board Member Tokyo, Japan
Reiko Mizushima Director, Managing Executive Officer and Board Member Tokyo, Japan
Hiroyuki Kuwazono Director, Senior Managing Executive Officer and Board Member 0 Tokyo, Japan
Chikara Shimizu Venture Capitalist Tokyo, Japan
You’re viewing 5 of 12 team members. Get the full list »

Nippon Venture Capital Co-Investors (78)

Name With Exits Lead Partner Series Industry
Mitsubishi UFJ Capital 5 0 Series chart Industry bar
SMBC Venture Capital 0 Series chart Industry bar
DG Ventures (Japan) 0 0 0 Series chart Industry bar
Eight Roads 0 0 0 Series chart Industry bar
Jafco 0 0 Series chart Industry bar
You’re viewing 5 of 78 co-investors. Get the full list »